- Home
- GRMN vs EW Comparison
GRMN vs EW Comparison
Compare GRMN & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRMN
- EW
- Stock Information
- Founded
- GRMN 1990
- EW 1958
- Country
- GRMN Switzerland
- EW United States
- Employees
- GRMN N/A
- EW N/A
- Industry
- GRMN Industrial Machinery/Components
- EW Industrial Specialties
- Sector
- GRMN Industrials
- EW Health Care
- Exchange
- GRMN Nasdaq
- EW Nasdaq
- Market Cap
- GRMN 40.1B
- EW 44.8B
- IPO Year
- GRMN 2000
- EW 2000
- Fundamental
- Price
- GRMN $212.75
- EW $77.13
- Analyst Decision
- GRMN Hold
- EW Buy
- Analyst Count
- GRMN 4
- EW 20
- Target Price
- GRMN $206.00
- EW $80.20
- AVG Volume (30 Days)
- GRMN 857.6K
- EW 3.6M
- Earning Date
- GRMN 07-30-2025
- EW 07-23-2025
- Dividend Yield
- GRMN 1.73%
- EW N/A
- EPS Growth
- GRMN 7.05
- EW 200.69
- EPS
- GRMN 7.59
- EW 7.02
- Revenue
- GRMN $6,450,353,000.00
- EW $5,522,300,000.00
- Revenue This Year
- GRMN $11.13
- EW $11.81
- Revenue Next Year
- GRMN $7.47
- EW $9.54
- P/E Ratio
- GRMN $27.48
- EW $11.14
- Revenue Growth
- GRMN 18.09
- EW 8.23
- 52 Week Low
- GRMN $158.90
- EW $58.93
- 52 Week High
- GRMN $246.50
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- GRMN 58.24
- EW 56.68
- Support Level
- GRMN $202.67
- EW $72.42
- Resistance Level
- GRMN $209.47
- EW $78.53
- Average True Range (ATR)
- GRMN 3.42
- EW 1.43
- MACD
- GRMN 0.37
- EW 0.24
- Stochastic Oscillator
- GRMN 77.04
- EW 80.20
About GRMN Garmin Ltd. (Switzerland)
Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing, among many others. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.